Methods and nucleotide fragments of predicting occurrence, metastasis of cancers and patients' postoperative survival in vitro
US9637797B2 · kind B2 · utility
1Cited by
0References
8Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 13, 2012 |
| Grant date | May 2, 2017 |
| Priority date | — |
| Expiry date | Feb 13, 2032 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG16B30/00
- WIPO fieldBiotechnology
- WIPO sectorChemistry
Abstract
Provided in the present invention are a method using in vitro measurement of the content of methylation or demethylation of GFRa1 CpG islands to estimate a risk of tumorigenesis and of tumor metastasis, or postoperative life expectancy, and a nucleotide sequence used.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.